The National Center for Tumor Diseases (NCT) Heidelberg is a joint venture of the German Cancer Research Center (DKFZ) and the Heidelberg University Hospital. German Cancer Aid (Deutsche Krebshilfe) funds the NCT as an Oncological Center of Excellence.
The National Center for Tumor Diseases (NCT) Heidelberg combines excellent patient care with innovative cancer research under one roof. State of the art research is to be translated as fast as possible into better treatment and prevention strategies. The NCT is coordinated by the following supervisory boards: Directorate, Steering Committee, and Scientific Advisory Board.